Found: 5
Select item for more details and to access through your institution.
FDA-approved disulfiram as a novel treatment for aggressive leukemia.
- Published in:
- Journal of Molecular Medicine, 2024, v. 102, n. 4, p. 507, doi. 10.1007/s00109-023-02414-4
- By:
- Publication type:
- Article
Exploiting the reactive oxygen species imbalance in high-risk paediatric acute lymphoblastic leukaemia through auranofin.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Building a Better Dynasore: The Dyngo Compounds Potently Inhibit Dynamin and Endocytosis.
- Published in:
- Traffic, 2013, v. 14, n. 12, p. 1272, doi. 10.1111/tra.12119
- By:
- Publication type:
- Article
Systematic In Vitro Evaluation of a Library of Approved and Pharmacologically Active Compounds for the Identification of Novel Candidate Drugs for KMT2A-Rearranged Leukemia.
- Published in:
- Frontiers in Oncology, 2022, v. 11, p. 1, doi. 10.3389/fonc.2021.779859
- By:
- Publication type:
- Article
Azido and Diazarinyl Analogues of Bis-Tyrphostin as Asymmetrical Inhibitors of Dynamin GTPase.
- Published in:
- ChemMedChem, 2009, v. 4, n. 7, p. 1182, doi. 10.1002/cmdc.200900054
- By:
- Publication type:
- Article